XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.25.1

EARNINGS PER SHARE (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
SCHEDULE OF BASIC AND DILUTED EARNINGS (LOSS) PER SHARE | The following table sets forth the computation of basic and diluted earnings (loss) per share: SCHEDULE OF BASIC AND DILUTED EARNINGS (LOSS) PER SHARE
|  | 2025 |  |  | 2024 |
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Numerator: |  |  |  |  |  |
Net income (loss) attributable to LifeMD, Inc. common stockholders - basic |  | $ | 608,241 |  |  | $ | (7,544,918 | )
Adjustment |  |  | - |  |  |  | - |
Net income (loss) attributable to LifeMD, Inc. common stockholders - diluted |  | $ | 608,241 |  |  | $ | (7,544,918 | )
Denominator: |  |  |  |  |  |  |  |
Weighted average number of common shares outstanding - basic |  |  | 43,135,778 |  |  |  | 39,242,237 |
Adjustment for the potential dilutive common shares |  |  | 2,444,533 |  |  |  | - |
Weighted average number of common shares outstanding - diluted |  |  | 45,580,311 |  |  |  | 39,242,237 |
Basic earnings (loss) per share of common stock |  | $ | 0.01 |  |  | $ | (0.19 | )
Diluted earnings (loss) per share of common stock |  | $ | 0.01 |  |  | $ | (0.19 | )
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES | The following table discloses the securities that were not included in the computation of diluted net earnings (loss) per share as their inclusion would have been anti-dilutive: SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES
|  | 2025 |  |  | 2024 |
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
RSUs and RSAs |  |  | 81,707 |  |  |  | 2,312,500 |
Stock options |  |  | 354,052 |  |  |  | 2,159,750 |
Warrants |  |  | 557,548 |  |  |  | 2,393,107 |
Convertible long-term debt |  |  | 671,141 |  |  |  | 671,141 |
Total |  |  | 1,664,448 |  |  |  | 7,536,498 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration